TMCnet News
RADISYS CORP FILES (8-K) Disclosing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits(Edgar Glimpses Via Acquire Media NewsEdge) Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Mr. Kevin C. Melia, an independent director of Radisys Corporation (the "Company"), died unexpectedly on June 17, 2014. Mr. Melia served as a member of the Company's audit committee and as chairman of the compensation and development committee. On June 18, 2014, the Company notified The NASDAQ Stock Market, LLC ("NASDAQ") of Mr. Melia's unexpected death, and that the Company has determined to rely on the cure period set forth in Listing Rule 5605(c)(4)(B) of the NASDAQ Listing Rules with respect to the requirement set forth in Listing Rule 5605(c)(2)(A) that the Company's audit committee be comprised of at least three independent directors. In order to regain compliance with Listing Rule 5605(c)(2)(A), the Company's board of directors has appointed Lorene K. Steffes, an independent director of the Company, to serve as a member of the audit committee effective immediately.Item 7.01 Regulation FD. On June 20, 2014, the Company issued a press release announcing that Kevin C. Melia, a director of the Company since July 2003, passed away. As a result, the Board of Directors of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Company, decreased the size of the Board of Directors of the Company to six members. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Exhibit 99.1 Press release, dated as of June 20, 2014 -------------------------------------------------------------------------------- |